Eran Blaugrund

Title: The Innovations of Eran Blaugrund

Introduction

Eran Blaugrund is a notable inventor based in Rehovot, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurological disorders. With a total of seven patents to his name, Blaugrund's work has had a meaningful impact on medical science.

Latest Patents

Among his latest patents is a method for the treatment of Restless Legs Syndrome, which involves administering R(+)-N-propargyl-1-aminoindan or a pharmaceutically acceptable salt thereof. This innovative approach aims to alleviate the symptoms associated with this condition. Another significant patent focuses on parenteral formulations of rasagiline, providing a method to preferentially inhibit monoamine oxidase A (MAOA) in the brain compared to the intestine. This formulation is designed to deliver a therapeutically effective amount of rasagiline or its salts.

Career Highlights

Eran Blaugrund is currently associated with Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. His work at Teva has allowed him to explore and develop groundbreaking treatments that address critical health issues.

Collaborations

Blaugrund has collaborated with several talented individuals in his field, including Nora Tarcic and Joel Kaye. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Eran Blaugrund's contributions to the pharmaceutical industry through his innovative patents demonstrate his commitment to improving patient care. His work continues to influence the treatment of neurological disorders, showcasing the importance of innovation in medicine.